Replies to post #73474 on Biotech Values

[DewDiligence]

Meanwhile, Biopartners is fuming over the EMEA’s rejection of Biferonex, its Avoxex/Rebif knockoff:

http://finance.yahoo.com/news/Biopartners-to-Appeal-the-bw-14418479.html